Αποτελέσματα Αναζήτησης
Cardiac shunt treatment varies depending on symptoms and severity. Small shunts may clear up (resolve) without treatment. Your healthcare provider may operate on a larger shunt to redirect blood flow. Common heart shunt surgeries include: Norwood procedure: This is an open-heart surgery typically done on newborns. Surgeons create a larger aorta ...
1 Μαΐ 2021 · We report the first-in-human use of the Alleviant device for the creation of a therapeutic interatrial shunt as a treatment for HFpEF. In this first published series, this implant-free procedure was safe and feasible with a promising efficacy signal that warrants further study.
2 Ιαν 2023 · Management of a shunt depends on the disease type and ranges from simple clinical observation, medical therapy, and lifestyle modification to surgical intervention. This activity reviews the evaluation and treatment of intracardiac shunts and highlights the role of the interprofessional team in evaluating and treating patients with this condition.
The creation of an atrial shunt is a novel approach for the management of heart failure. For many patients, a principal determinant of symptoms and impaired functional capacity is elevation in left atrial pressure, which may be considered a “final common pathway” for a variety of cardiac disease states.
In cardiology, a cardiac shunt is a pattern of blood flow in the heart that deviates from the normal circuit of the circulatory system. It may be described as right-left, left-right or bidirectional, or as systemic-to-pulmonary or pulmonary-to-systemic.
21 Ιουν 2016 · In this article, we give the rationale for a therapeutic transcatheter interatrial shunt device in HFpEF, and we describe the design of REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I), the first randomized controlled trial of a device-based therapy to reduce left atrial pressure in HFpEF. Clinical Trial Registration—
4 Δεκ 2023 · Transcatheter atrial shunt therapies, designed to dynamically lower left atrial (LA) pressure by shunting blood into the larger reservoir of the right atrium and central veins, have been developed as a novel treatment for heart failure (HF) over the past 10+ years.
